Form 4: Jaguar Health Executive Steven R. King Reports Stock Transaction

Steven R. King, Chief of Sustainable Supply, Ethnobotanical Research and Intellectual Property and Secretary at Jaguar Health, Inc., reports a transaction involving restricted stock units converting into common stock.

Summary

• On May 17, 2025, Steven R. King, an officer of Jaguar Health, Inc., reported a transaction involving the conversion of restricted stock units into common stock.
• The transaction involved 1 restricted stock unit converting into 145 shares of common stock.
• The reported transaction reflects adjustments due to multiple reverse stock splits: a 75-for-1 split on January 23, 2023, a 60-for-1 split on May 23, 2024, and a 25-for-1 split on March 18, 2025.
• The restricted stock units were originally approved on March 28, 2022, and vest in three equal annual installments starting May 17, 2023.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, so the sentiment is neutral.

Industry Context

Form 4 filings are standard disclosures required by the SEC to ensure transparency in insider trading activities, providing investors with insights into the transactions of company executives and directors.

Stakeholder Impact

• The transaction provides shareholders with information about executive compensation and stock ownership.
• The filing ensures transparency and compliance with SEC regulations.

Key Dates

Keywords

Jaguar Health, Steven R. King, stock transaction, restricted stock units, common stock, reverse stock split, Form 4